secwatch / observer
8-K filed October 5, 2023, 7:59 PM ET CIK 0001566469
debt confidence high sentiment negative materiality 0.85

NantHealth, Inc.: debt financing — NantHealth receives $75M note repurchase demand from Highbridge; capital commitments from Nant Capital

NantHealth, Inc.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.85

NantHealth, Inc. reported a default on convertible notes of approximately $75 million in aggregate principal amount of Convertible Notes with Highbridge Capital Management, LLC at accrued interest (rate not specified) maturing October 18, 2023.

Instrument
convertible notes
Principal
approximately $75 million in aggregate principal amount of Convertible Notes
Counterparty
Highbridge Capital Management, LLC
Rate
accrued interest (rate not specified)
Maturity
October 18, 2023
Event
default
Exact text from the filing
On September 29, 2023, NantHealth, Inc. (the " Company ") received notice from U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association) (the " Trustee ") that, pursuant to the terms of the Amended and Restated Indenture, dated as of May 17, 2023 (as amended, restated, modified or supplemented from time to time, the " Convertible Notes Indenture "), by and among the Company, as issuer, NaviNet, Inc. and OpenNMS Group, Inc., as guarantors, and the Trustee, that Highbridge Capital Management, LLC and its affiliated funds (" Highbridge "), as holders of approximately $75 million in aggregate principal amount of Convertible Notes (the " Notes "), have exercised their right under the Convertible Note Indenture to require the Company to repurchase their Notes (the " Repurchase Right ") on October 18, 2023.
View on SEC.gov

Browse all debt financings →

Source: SEC EDGAR
accession 0001566469-23-000063
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.